Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Hong Li

Showing results (171-180 of 324) with videos related to

Pageof 33
Sort By:
Medical Oncology (Northwood, London, England)|November 6, 2010
A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in ChinaMiao-Zhen Qiu, Dong-Sheng Zhang, Dan-Yun Ruan, et al.
Huan Jing Ke Xue= Huanjing Kexue|July 2, 2020
[Water Sources and Factors Controlling Hydro-chemical Compositions in the Yiluo River Basin]Song-Tao Liu, Dong Zhang, Yu-Hong Li, et al.
Natural Product Research|June 17, 2025
Three new <i>ent</i>-kaurene diterpenoid glucosides from the flowers of <i>Inula japonica</i> ThunbZheng Niu, Jia-Qi Chen, Guan-Ke Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 17, 2004
[Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases]Hui-Qiang Huang, Wen-Qi Jiang, Yu-Long Peng, et al.
American Journal of Clinical Oncology|November 22, 2011
Phase 2 study of capecitabine and irinotecan combination chemotherapy (modified XELIRI regimen) in patients with advanced gastric cancerHui-Yan Luo, Zhi-Qiang Wang, Feng-Hua Wang, et al.
Journal of Cancer Research and Clinical Oncology|August 13, 2017
Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinomaFei Zhang, Yun Wang, Peng Sun, et al.
Annals of Surgical Oncology|November 3, 2023
A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical TrialJia-Di Wu, Zhi-Qiang Wang, Qiao-Qiao Li, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 24, 2010
Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in ChinaMiao-zhen Qiu, Rui-hua Xu, Dan-yun Ruan, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 22, 2016
Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysisFei Zhang, Yun Wang, Zhi-Qiang Wang, et al.
Cancer|March 17, 2004
Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinomaJian-Yong Shao, Yu-Hong Li, Hong-Yi Gao, et al.
Pageof 33

Showing results (171-180 of 324) with videos related to

Sort By:
Pageof 33
Medical Oncology (Northwood, London, England)|November 6, 2010
A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in ChinaMiao-Zhen Qiu, Dong-Sheng Zhang, Dan-Yun Ruan, et al.
Huan Jing Ke Xue= Huanjing Kexue|July 2, 2020
[Water Sources and Factors Controlling Hydro-chemical Compositions in the Yiluo River Basin]Song-Tao Liu, Dong Zhang, Yu-Hong Li, et al.
Natural Product Research|June 17, 2025
Three new <i>ent</i>-kaurene diterpenoid glucosides from the flowers of <i>Inula japonica</i> ThunbZheng Niu, Jia-Qi Chen, Guan-Ke Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 17, 2004
[Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases]Hui-Qiang Huang, Wen-Qi Jiang, Yu-Long Peng, et al.
American Journal of Clinical Oncology|November 22, 2011
Phase 2 study of capecitabine and irinotecan combination chemotherapy (modified XELIRI regimen) in patients with advanced gastric cancerHui-Yan Luo, Zhi-Qiang Wang, Feng-Hua Wang, et al.
Journal of Cancer Research and Clinical Oncology|August 13, 2017
Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinomaFei Zhang, Yun Wang, Peng Sun, et al.
Annals of Surgical Oncology|November 3, 2023
A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical TrialJia-Di Wu, Zhi-Qiang Wang, Qiao-Qiao Li, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 24, 2010
Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in ChinaMiao-zhen Qiu, Rui-hua Xu, Dan-yun Ruan, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 22, 2016
Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysisFei Zhang, Yun Wang, Zhi-Qiang Wang, et al.
Cancer|March 17, 2004
Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinomaJian-Yong Shao, Yu-Hong Li, Hong-Yi Gao, et al.
Pageof 33